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Abstract
At present, it is unclear if melanocytes contain Cx43 gap junctions and whether Cx43 expression
is regulated in melanoma onset and progression. To this end, we cultured pure populations of
mouse melanocytes and found that they had no detectable Cx43 and exhibited an inability for dye
transfer indicating they were devoid of functional gap junctions. Given the evidence that
melanomas acquire the expression of other connexin isoforms during tumor progression, we
assessed if Cx43 was also expressed and assembled into gap junctions at any stage of human
melanoma onset and progression to distant metastases. Nearly all primary melanomas within the
epidermis lacked Cx43. In contrast, nodal metastases expressed low levels of Cx43 which was
markedly higher in distant metastases that had invaded vital organs. Importantly, in all stages of
melanoma progression, Cx43 could be detected in intracellular compartments but was rarely
assembled into gap junctions indicative of functional gap junction channels. Overall, these studies
suggest that melanocytes do not form Cx43 homocellular gap junctions and even though Cx43
levels increase during melanoma progression, this connexin rarely assembles into gap junction
structures.
Key words: connexin; gap junctions; gap junctional intercellular communication; Cx43; melanoma.

Introduction
Connexins encompass a large family of integral
membrane proteins that form gap junction channels to
allow for the intercellular exchange of metabolites and
small molecules (< 1 kDa), termed gap junctional
intercellular communication (GJIC) [1]. Connexin
proteins oligomerize into hexameric channels (termed
connexons), which translocate to the plasma
membrane where they can dock with a connexon
from an adjacent cell to form a gap junction channel
for direct exchange of cytosolic signaling molecules
[2]. The expression profile of connexins is
tissue-specific and can be altered in many pathologies
including skin cancers, highlighting their complex
regulation during disease [3].
Despite the vast array of connexin isoforms
expressed throughout the keratinocyte layers,
surprisingly little is known about the connexin profile

of melanocytes [4, 5]. This sparsity of connexin
knowledge also extends to mouse melanocytes even
though mice have been used as experimental models
for in vivo melanoma progression. One study suggests
that human melanocytes exhibited GJIC with
co-cultured keratinocytes a process that was mediated
by the expression of E-cadherin [5]. These same
authors went on to show that a melanoma cell line lost
the ability to communicate with keratinocytes but this
was replaced with the acquired ability to express
N-cadherin and establish GJIC with fibroblasts [5].
Tissue microarray analysis of primary cutaneous
human melanomas revealed increased Cx43
expression in comparison to melanocytic nevi,
pointing to a possible role for Cx43 as a tumor
facilitator [6]. This notion was supported by Sargen
and colleagues who suggested that primary human
http://www.jcancer.org
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melanomas exhibited more Cx43 immunostaining
than benign nevi although they did not assess
melanomas that had invaded nodes or had
metastasized to distant organs [7]. In contrast, Haass
and colleagues reported no Cx43 staining in human
melanocytic nevi and malignant melanomas in situ
questioning the extent of Cx43 regulation in
melanoma tumorigenesis [8]. In all of these studies no
clear distinctions were made between Cx43
expression and its in vivo assembly into prototypical
gap junctions indicative of its functioning in cell-cell
communication. Given these conflicting observations,
a thorough characterization of the expression and
localization of Cx43 throughout the different stages of
human melanoma progression remains to be
investigated.

Materials and Methods
Primary Mouse Keratinocyte and Melanocyte
Cultures
The dorsal skin was collected from wild type
mouse neonates (2-3 days of age) as previously
described [9]. Isolation of primary mouse melanocytes
was accomplished as previously described [10], with
the following modifications. Following dispase
incubation, 6-8 epidermises were separated, minced,
and transferred to tubes containing 0.25%
Trypsin/EDTA solution. The epidermis was then
incubated on a rocker at 37°C, and then the
Trypsin/EDTA was neutralized. The suspension was
passed through a 70-µm strainer, and centrifuged for
10 mins at 1000 rpm. The pellet was re-suspended in 5
ml of Clonetics Melanocyte Growth Medium-4
(MGM-4 Bullet Kit, CC-3249). Cells (1 x 106) were
plated on 60 mm dishes. Melanocytes were passaged
when they were 80% confluent. Cells analyzed by
immunohistochemistry were plated on coverslips
coated with rat-tail collagen type 1 (BD Biosciences,
354236). Coverslips with attached melanocytes were
removed, washed in PBS (pH 6.8) and fixed in 4%
PFA for 20 minutes at 25˚C. PFA was removed and
fixed cells were washed three times in PBS (pH 6.8),
prior
to
incubation
with
0.1%
L-3,4dihydroxyphenylalanine (L – DOPA) (Alfa Aesar,
A11311) for 4 hrs at 37°C, as previously described [11].
Coverslips were subsequently washed with PBS (pH
6.8) before being mounted on glass slides with
Permount and five images were taken for each
passage using a LSM 800 Zeiss confocal microscope
using a 40x lens. Images were blinded to the
investigator and melanocyte purity was calculated by
measuring the percent yield of L-DOPA positive cells
(dark pigmented cells) verses total cells in an image
area. For primary keratinocyte cultures, keratinocytes
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were cultured as previously described by Churko et
al. 2012 [9]. To induce keratinocyte differentiation,
primary cells were placed in 1.4 mM calcium 24 hrs
after isolation, and maintained for an additional 24
hrs before use [9].
In some cases, keratinocytes and/or melanocytes
were washed in PBS, and fixed in 4% PFA for 20 mins
at 25ºC. Cells were labeled with either mouse
anti-tyrosinase related protein 1 (TRP1, 1:200; Abcam
3312), mouse anti-E-cadherin (1:200; BD Transduction
Labs, 610182) or rabbit anti-Cx43 (Sigma Cat# C6219,
1:400) overnight at 4°C. Subsequently, cells were
incubated with Alexa Fluor 555-conjugated anti-rabbit
(1:400; Molecular Probes) or Alexa Fluor
488-conjugated anti-mouse (1:400; Molecular Probes)
for 1 hour at 25ºC followed by Hoescht 33342 staining
for 10 mins at 25ºC (1:1000; Molecular Probes, H3570)
prior to mounting using Airvol and imaged by
confocal microscopy [12].

Calcein-AM Dye Transfer
P2 primary mouse melanocytes and rat
epidermal keratinocytes (REKs), which were
previously isolated and characterized [13], were
grown to confluence on glass bottom dishes in
Dulbecco’s Modified Eagle Medium (DMEM, 10%
FBS), and GJIC was evaluated using Calcein-AM
loading as previously described [14]. Cells (N = 30)
were photo-bleached to 20% of original staining
intensity using a 488 nm argon laser (80% power).
Images were captured every 3 seconds until
maximum recovery was reached (15 mins) using a
LSM 800 Zeiss confocal microscopic using a 40x lens.
Ten cytosolic areas (2 mm2) in bleached cell and
unbleached non-adjacent cells were selected and
mean fluorescence intensity was measured over the
time course of the experiment using ImageJ Time
Series Analyzer V3.

Human Melanoma Biopsies
Human melanoma samples and normal controls
were provided by the Ontario Tumor Bank, which is
funded by the Ontario Institute of Cancer Research
(OICR). All specimens were verified by a pathologist
at the OICR before use. Paraffin embedded sections (5
µm) of primary cutaneous tumor (N = 14), nodal
melanoma metastases (N = 15), and melanoma
metastases from distant organ sites (N = 7), in
addition to normal controls (N = 7) were selected. All
work with human specimens was approved by The
Human Science Research Ethics Board at the
University of Western Ontario. Paraffin embedded
sections were deparaffinized, subjected to antigen
retrieval, and probed with rabbit anti-Cx43 (1:300;
Sigma-Aldrich, C6219) or rabbit anti-MITF (1:200;
http://www.jcancer.org
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Abcam, 20663) antibodies, overnight at 4°C prior to
labeling with secondary antibodies as described
above. To avoid the possible inclusion of adjacent
normal tissue in analysis, 5-10 images of the tumor
core and its surrounding radius of all samples was
imaged using the 40x objective of the Zeiss LSM 800
confocal microscope. Images were then classified
relatively as possessing no, low or high intensity of
Cx43, and plaques were identified as punctate
structures (0.2-1 µm in size) at the interface of two
adjacent cells. Tissues were imaged blinded to the
investigator to mitigate bias.

Results and Discussion
While it is abundantly clear that Cx43 is
expressed in keratinocytes [4, 15], it’s expression and
role in melanocytes is far less defined. This problem is
primarily due to the small population of melanocytes
in the epidermis [16] and the difficulty in obtaining
sufficiently high resolution immunolabeled images in
situ to distinguish which skin cell types are truly
expressing Cx43. To better elucidate whether Cx43 is
expressed in melanocytes and the possible role of
GJIC, we examined cultured mouse melanocytes for
connexin expression and/or intercellular coupling.
Primary mouse melanocytes were successfully
isolated as evidence by positive expression for the
melanogenesis markers, L-DOPA and TRP1 (Fig. 1A,
B). Furthermore, the percent yield of L-DOPA positive
melanocytes (dark pigment) was calculated across all
passages (P2-P4), and the cultures were identified as
>90% melanocyte monocultures (Fig. 1A). While Cx43
positive plaques were readily detectable at the cell
surface of rat epidermal keratinocytes (REKs) (Fig.
1C) and primary mouse keratinocytes before and after
differentiation in the presence of high calcium (Fig.
1D), primary mouse melanocytes showed no evidence
of Cx43 expression. To assess for intercellular
coupling that could be facilitated by the presence of
any member of the connexin family, keratinocytes and
primary (P2) melanocytes were incubated with
calcein-AM
dye
and
dye
recovery
after
photobleaching was measured. Primary melanocytes
did not show any evidence of calcein-AM dye
recovery after photobleaching compared to
Cx43-positive REKs (Fig. 1E, F). Collectively, this
indicates that primary mouse melanocytes are
Cx43-negative and have no detectable levels of
functional connexins capable of dye transfer.
If Cx43 fulfills the role of a tumor promoter in
melanomas, one would predict that it would be
up-regulated during disease onset and progression.
The fate of Cx43 in melanoma progression and in
distant metastasis are unclear [6-8]. However, our
finding that primary melanocytes lack detectable
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Cx43 and GJIC leaves open the possibility that Cx43
expression and gap junction assembly may be
upregulated during melanoma tumorigenesis. Thus,
to better characterize the role of Cx43 in human
melanoma, the tumor core and surrounding radius of
primary melanomas, in addition to nodal and distant
metastases, were evaluated by immunofluorescence
and imaging for low or high Cx43 expression and for
the assembly of gap junctions. Consistent with Cx43
being absent from melanocytes, primary melanomas
also showed no evidence of Cx43 expression (90% of
images from all donors), and in the rare cases where
Cx43 was evident, it did not localize to gap junction
plaques (Fig. 2A). As a control, Cx43 was readily
detected in gap junctions in keratinocyte-rich normal
skin (Fig. 2A). In addition, the majority of melanomas
that metastasized to the lymph nodes did not express
Cx43 (75%), and while more Cx43 localized to
intracellular regions in tumors defined as expressing
high (9%) and low (14%) levels, few to no gap junction
plaques could be identified (2%) (Fig. 2B).
Interestingly, the majority of samples collected from
melanoma metastases to distant organs expressed
Cx43 within intracellular compartments at both high
(37%) and low (34%) levels. However, consistent with
other stages of the disease, very few gap junction
plaques were identified (8%) (Fig. 2C). Furthermore,
distant sites of metastasis which were also included in
the Cx43 expression analysis (lung, femur, pelvic wall,
kidney), stained positive for MITF confirming the
tumor core and its surrounding radius was of
melanocytic origin (Fig. 2D).
Using a library of human melanomas, we found
that Cx43 protein was minimally expressed in
primary cutaneous tumors and melanoma metastases
to nodal tissue, but was expressed at moderate to high
levels in melanoma metastases to distant organ sites.
However, Cx43 expression remained largely
intracellular; suggesting that any possible causal role
Cx43 played in tumor progression would have to be
gap
junction-independent.
Many
gap
junction-independent roles for Cx43 have been
proposed but most involve the Cx43 interactome,
which exceeds over 30 proteins, some of which have
been linked to cancer or cell proliferation pathways,
including NOV/CCN3, SRC, and caveolin -1 [17-19].
The inability of tumor cells to form Cx43-based gap
junctions may be linked to a tumor survival
mechanism, particularly to prevent the passage of
molecules such as glutathione that assist in
detoxifying carcinogens [20]. In our other studies,
forced expression of Cx43 in B16-BL6 mouse
melanomas resulted in increased GJIC which reduced
the tumorigenic properties of the cells in both culture
and in chicken chorioallantoic membranes [21]. If
http://www.jcancer.org
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these mouse melanoma studies did indeed translate to
the clinic this might suggest that Cx43 could be tumor
suppressive in melanomas if it was successfully
assembled into functional gap junctions; a process
that is clearly defective in the human melanomas
investigated here. Interestingly, it has been reported
that Cx26 is upregulated in metastatic mouse
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melanomas where it could serve to form intercellular
channels amongst melanomas or between melanomas
and endothelial cells during extravasation [22]. Thus,
Cx26 may be serving a very different role in
melanoma tumorigenesis from Cx43 but targeting
either or both connexins in advanced melanoma
disease may have therapeutic advantages.

Figure 1: Primary mouse melanocytes show no evidence of Cx43 expression or GJIC Primary mouse melanocytes stained positive for L-DOPA (black
pigment) (A) and were essentially pure across passage P2 and P3 (N = 3, n = 15), as revealed by staining for TRP1 (B; red). (C) Melanocytes exhibited no evidence of
Cx43 expression, in comparison to Cx43-rich REKs, and (D) undifferentiated and differentiated primary mouse keratinocytes, which show evidence of Cx43 GJs
(arrows) at the junctional membrane (E-cad= E-cadherin). (E) Outlined melanocytes loaded with calcein dye were photobleached and dye recovery was measured
every 3 seconds for 450 seconds. In contrast to photobleached REKs (N = 3, n = 30), photobleached melanocytes (N = 3, n = 30) did not receive calcein dye indicating
lack of GJIC. (F) Quantified data illustrates fluorescence recovery. Bars represent mean +/- SEM. Scale bar = 20 μm.

http://www.jcancer.org
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Figure 2: Increased intracellular Cx43 in distant human melanoma metastases (A) The majority of images analyzed from primary melanoma (N = 14), and
(B) nodal metastases (N = 15) did not show evidence of Cx43 expression as opposed to normal skin where Cx43 gap junctions were abundant (A). In contrast, (C)
the majority of images analyzed from melanoma metastases to distant organ sites (N = 7) showed evidence of Cx43 expression, however, this expression was
predominately intracellular and did not form gap junction plaque-like structures indicative of potentially functional gap junction channels. Arrows indicate punctate
Cx43 gap junction structure at the cell-cell interface. (D) Regardless of the distant organ site of melanoma metastases, tumor cores from lung, femur, pelvic wall, and
kidney stained positive for MITF, indicating the tumor was from a melanocytic cell lineage. Bars represent mean +/- SEM. Scale bar = 20 μm.

Overall, we found that primary mouse
melanocytes in monoculture did not express
detectable Cx43 and are not GJIC dye-coupled with
neighboring cells. This challenges the putative role of
Cx43 as a potential regulator of melanocyte
proliferation and tumor suppressor at early stages of
melanocyte transformation. While we did not assess

Cx43 and GJIC in human melanocyte cultures, it was
notable that nearly all primary human melanomas
investigated (N=14) lacked Cx43 suggesting that even
if there were very low levels of Cx43 in human
melanocytes, they were quickly lost upon the onset of
tumorigenesis. The general increase in intracellular
Cx43 levels in melanomas that invaded lymph nodes
http://www.jcancer.org
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followed by a further increase in intracellular Cx43 in
melanomas that had distally metastasized correlates
with the hypothesis that intracellular Cx43 is
providing the tumor cells with a survival advantage
but a causal relationship awaits further studies.
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